Analytical Data
-
基因名
RPL22
- Application
-
别名
RPL22;Large ribosomal subunit Protein eL22
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P35268
-
表达区间
1-128aa
-
氨基酸序列
MGSSHHHHHH SSGLVPRGSH MGSMAPVKKL VVKGGKKKKQ VLKFTLDCTH PVEDGIMDAA NFEQFLQERI KVNGKAGNLG GGVVTIERSK SKITVTSEVP FSKRYLKYLT KKYLKKNNLR DWLRVVANSK ESYELRYFQI NQDEEEEEDE D
-
分子量
17 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RPL22, a ribosomal protein located in the 60S subunit of the ribosome, plays a crucial role in protein synthesis within eukaryotic cells. Recent studies have indicated that RPL22 is involved not only in ribosome biogenesis but also in various cellular processes, including stress responses and cell proliferation. Importantly, aberrations in RPL22 expression have been linked to several diseases, including cancer, where its downregulation can lead to disrupted protein synthesis and altered cell signaling pathways. Researchers have been exploring RPL22 as a potential biomarker for tumor progression and a target for therapeutic intervention. The recombinant expression of RPL22 provides a valuable tool for investigating its functional roles and interactions in ribosome assembly and cellular functions. By producing RPL22 as a recombinant protein, scientists can conduct detailed studies on its structure, binding properties, and regulatory mechanisms. This research could illuminate the significance of RPL22 in both normal physiological processes and disease states, offering insights into novel therapeutic strategies aimed at modulating its function or compensating for its loss in disease contexts. Overall, the investigation of RPL22 and its recombinant form holds promise for advancing our understanding of fundamental biological processes and their implications in human health and disease.
